Coherent Corp. (COHR)
Quantitative Summary
DeterministicCOHR trades at 172.1x earnings — a 165% premium to its sector average of 65.0x — without a dominant ROIC-WACC spread. Financial health metrics are strong: Piotroski 7/9, Altman Z 6.1 (above 3.0 safe zone threshold). DCF fair value of $5 implies 98% downside based on model assumptions.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics present a stark divergence between aggressive top-line expansion and deteriorating capital efficiency. While revenue growth of 23.4% suggests strong market traction, the ROIC-WACC spread stands at -13.6%, indicating that current investments are destroying value relative to the cost of capital. This inefficiency is further illuminated by DuPont decomposition, where an exceptionally low asset turnover of 0.39x drags total ROE down to just 0.6% despite a respectable gross margin of 35.2%. Although qualitative distress signals appear muted with a Piotroski F-Score of 7/9 and a Beneish M-Score of -2.54 suggesting low earnings manipulation risk, the Altman Z-Score of 5.1 points to moderate financial stability rather than immediate insolvency. The combination of weak profitability factors (RMW: -0.223) and negative value factor exposure (HML: -0.754) highlights a company struggling to generate returns on its asset base through operational leverage or margin expansion.
Valuation metrics reflect extreme market optimism that appears misaligned with the underlying capital generation capabilities. The current P/E ratio of 250.6x vastly exceeds historical norms and implies an unrealistic expectation for future earnings acceleration, particularly given the near-zero net margin of 0.9%. A DCF analysis yields a fair value estimate significantly below current trading levels, implying -97.6% downside if the model's assumptions regarding cash flow generation hold true. This valuation gap is sustained only by an implied free cash flow growth rate of 50.0%, which assumes hyper-growth that contradicts the observed weak profitability and negative spread between returns on invested capital and the weighted average cost of capital.
Risk-adjusted performance data reveals significant volatility in risk premiums, with a Fama-French Alpha of 45.16% annualized suggesting substantial excess return over recent periods despite unfavorable factor tilts. However, insider activity presents a counterweight to this momentum, as $4.9 million in net selling over the last 90 days indicates internal stakeholders may be reducing exposure ahead of potential valuation corrections or earnings disappointments. The confluence of negative value and profitability factors alongside substantial insider outflows suggests that while recent alpha generation has been robust, the risk/reward profile is increasingly skewed toward downside volatility if growth rates decelerate from their current trajectory.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 23% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 13.7% | 15.7% | 17.7% |
|---|---|---|---|
| 2% | $8 | $4 | $2 |
| 3% | $10 | $5 | $2 |
| 4% | $12 | $7 | $3 |
Center = base case. Green = >10% upside, Red = >10% downside vs $426.89.
Pre-computed DCF: WACC=15.7%, terminal growth 3%. Fair value $5 (-98.2%). Not investment advice.
Valuation Context
Currently trading 53% above its 5-year average P/E of 198.5x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedCoherent Corp. is currently trading at $362.83 within the technology sector, presenting a specific technical snapshot that requires careful interpretation of its momentum and trend dynamics. The immediate analysis hinges on the relationship between the current price action and established moving averages to determine the prevailing directional bias. If the stock price remains positioned above these key average lines, it typically signals an uptrend where bullish sentiment may be sustaining higher valuations. Conversely, a position below these averages would suggest a corrective phase or bearish dominance in the short term. The Relative Strength Index (RSI) serves as a critical gauge for assessing short-term momentum without indicating future price direction definitively. A reading near overbought levels could imply that recent gains have been aggressive and might face resistance, while an oversold condition often points to potential exhaustion of selling pressure. In this context, the interplay between the current $362.83 valuation and these technical indicators offers a window into market sentiment rather than a forecasted outcome. Traders observing this setup must weigh whether the price is finding support above its moving averages or encountering resistance below them, allowing for an independent assessment of whether momentum is accelerating or decelerating in the near future.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like VBK or SMMD, the fund manager is mechanically forced to buy or sell COHR shares regardless of Coherent Corp.'s individual fundamentals. We estimate $7.2B of passive capital is structurally linked to COHR through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Coherent Corp. to visualize passive redemption contagion across ETFs and collateral stocks.
If Coherent Corp. (COHR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA CORP (NVDA) as the most exposed collateral stock, sharing 1 ETFs with COHR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 19 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
COHR Ownership Dynamics
Passive funds hold 1 in every 8 COHR shares, reducing daily market volatility.
Coherent Corp. (COHR) exerts measurable gravity on the passive index market, currently representing 0.9% of the VBK (VBK) and 0.7% of the SMMD (SMMD). Across 19 tracked ETFs, approximately 25M shares (13.0% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest COHR Exposure
Float lock-up computed from 19 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
COHR Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Coherent Corp. over the past year sits near $100.84 (11% of 252-day volume). The current price of $426.89 trades 323.4% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
COHR Capital Efficiency
How efficiently does Coherent Corp. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Coherent Corp. converts 22% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 78% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-13.7%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 133 | $403.71 | $53,693.43 |
| 2026-05-11 | 210 | $335.26 | $70,404.6 |
| 2026-05-08 | 95 | $319.19 | $30,323.05 |
| 2026-05-05 | 18,131 | $329.89 | $6.0M |
| 2026-05-04 | 2,205 | $329.50 | $726,547.5 |
| 2026-04-30 | 16,024 | $304.93 | $4.9M |
| 2026-04-21 | 512 | $347.51 | $177,925.12 |
| 2026-04-20 | 8,900 | $345.02 | $3.1M |
| 2026-04-13 | 1,615 | $307.50 | $496,612.5 |
| 2026-04-09 | 16,735 | $281.79 | $4.7M |
| 2026-04-06 | 800 | $258.16 | $206,528 |
| 2026-03-31 | 37,346 | $219.65 | $8.2M |
| 2026-03-24 | 650 | $255.05 | $165,782.5 |
| 2026-03-23 | 49,359 | $253.63 | $12.5M |
| 2026-03-17 | 6,830 | $247.37 | $1.7M |
| 2026-03-09 | 1,500 | $235.72 | $353,580 |
| 2026-03-05 | 1,462 | $274.86 | $401,845.32 |
| 2026-02-27 | 142 | $250.14 | $35,519.88 |
| 2026-02-23 | 1,592 | $248.18 | $395,102.56 |
| 2026-02-17 | 1,400 | $217.23 | $304,122 |
| 2026-02-09 | 593 | $227.68 | $135,014.24 |
| 2026-02-06 | 6,706 | $209.24 | $1.4M |
| 2026-01-29 | 104,994 | $221.14 | $23.2M |
| 2026-01-21 | 1,257 | $193.46 | $243,179.22 |
| 2026-01-20 | 1,033 | $191.04 | $197,344.32 |
| 2026-01-06 | 1,208 | $186.36 | $225,122.88 |
| 2025-12-30 | 212 | $189.02 | $40,072.24 |
| 2025-12-29 | 200 | $191.72 | $38,344 |
| 2025-12-22 | 96,909 | $185.83 | $18.0M |
| 2025-12-16 | 3,976 | $178.45 | $709,517.2 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| LITE | 0.713 | 0.745 | High co-movement |
| FN | 0.694 | 0.700 | Moderate |
| CIEN | 0.689 | 0.739 | Moderate |
| GLW | 0.654 | 0.741 | Moderate |
| AAOI | 0.579 | 0.577 | Moderate |
| LRCX | 0.571 | 0.604 | Moderate |
| VRT | 0.561 | 0.521 | Moderate |
| PWR | 0.549 | 0.605 | Moderate |
| FIX | 0.547 | 0.616 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare COHR to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.